Viracta Therapeutics, Inc. Annual Interest Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Viracta Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2011 to 2023.
  • Viracta Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $679K, a 28.8% decline year-over-year.
  • Viracta Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $3.18M, a 8.26% increase year-over-year.
  • Viracta Therapeutics, Inc. annual Interest Expense for 2023 was $3.7M, a 542% increase from 2022.
  • Viracta Therapeutics, Inc. annual Interest Expense for 2022 was $577K, a 17.5% increase from 2021.
  • Viracta Therapeutics, Inc. annual Interest Expense for 2021 was $491K, a 127% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.7M +$3.13M +542% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $577K +$86K +17.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $491K +$275K +127% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $216K +$173K +404% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $42.8K -$1.11M -96.3% Jan 1, 2019 Dec 31, 2019 8-K/A 2021-03-23
2018 $1.15M -$242K -17.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $1.4M -$325K -18.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $1.72M +$782K +83.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 $939K -$780K -45.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $1.72M -$1.2M -41.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $2.92M +$1.06M +57.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $1.86M +$1.6M +616% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $259K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.